FKBP5 and depressive symptom measurement: Based on these observations in mice, and because of its potential clinical utility as a biomarker of vulnerability to stress, we determined in a large human cohort (Netherlands Study of Depression and Anxiety, NESDA) whether plasma IGF-I levels were related with measures of stress exposure, HPA activity, and FKBP5.